menu
    • menu

    Company profile for Petros Pharmaceuticals

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Petros Pharmaceuticals was founded upon its first, and currently commercialized Men’s Health therapeutic, a distinct molecule in erectile dysfunction, with an aim to continue awareness, education and therapeutic value to the Men’s sexual dysfunction landscape.In a continued effort to expand its portfolio into other underserved segments, Petros Pharmaceuticals has recently executed a definitive global exclusive licensing ag...
    Petros Pharmaceuticals was founded upon its first, and currently commercialized Men’s Health therapeutic, a distinct molecule in erectile dysfunction, with an aim to continue awareness, education and therapeutic value to the Men’s sexual dysfunction landscape.In a continued effort to expand its portfolio into other underserved segments, Petros Pharmaceuticals has recently executed a definitive global exclusive licensing agreement for a novel and patented topical formulation candidate for the treatment of Peyronie’s disease.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Petros PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    New York, NY 10036
    Telephone
    Telephone
    1-973-242-0005
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.petrospharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/petros-pharmaceuticals/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Petros Exits Metuchen to Strengthen Balance Sheet
    Petros Exits Metuchen to Strengthen Balance Sheet

    25 Jun 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/petros-pharmaceuticals-announces-deconsolidation-of-metuchen-pharmaceuticals-subsidia-1042801

    ACCESSWIRE
    25 Jun 2025
    Share Share
    Petros Pharmaceuticals Moves from Nasdaq to OTC Markets
    Petros Pharmaceuticals Moves from Nasdaq to OTC Markets

    21 May 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/petros-pharmaceuticals-announces-transition-from-nasdaq-to-otc-markets-1030209

    ACCESSWIRE
    21 May 2025
    Share Share
    Petros Pharma partners with Innolitics for software Developer
    Petros Pharma partners with Innolitics for software Developer

    20 May 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/petros-pharmaceuticals-partners-with-innolitics-a-leading-software-as-a-medical-devic-1029717

    ACCESSWIRE
    20 May 2025
    Share Share
    Petros Pharmaceuticals Enhances AI Platform with Big Data Partner
    Petros Pharmaceuticals Enhances AI Platform with Big Data Partner

    06 May 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/petros-pharmaceuticals-strengthens-partnership-with-market-leading-big-data-provider-1023866

    ACCESSWIRE
    06 May 2025
    Share Share
    Petros Pharma Developing AI-Based SaaS Platform for Rx-OTC Switches
    Petros Pharma Developing AI-Based SaaS Platform for Rx-OTC Switches

    01 May 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/petros-pharmaceuticals-developing-first-in-industry-saas-platform-utilizing-ai-and-el-1022151

    ACCESSWIRE
    01 May 2025
    Share Share
    Petros Tech Aligns with President Trump Order on Rx-to-OTC Reform
    Petros Tech Aligns with President Trump Order on Rx-to-OTC Reform

    29 Apr 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/petros-proprietary-technology-platform-aligns-with-april-15-2025-president-trump-exec-1020992

    ACCESSWIRE
    29 Apr 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search